The Wegovy maker has signed a deal to license an experimental obesity pill from China’s Jiangsu Hengrui Pharmaceuticals as it seeks to regain share of the global GLP-1 market.
Culture. Cinema. Style.Magazine
THE SMSA NEWS APPYour world. Wherever you are.Discover the app ↗↗



